Report overview
Gigantism refers to abnormally high linear growth due to excessive action of insulinlike growth factor I (IGF-I) while the epiphyseal growth plates are open during childhood. Acromegaly is the same disorder of IGF-I excess but occurs after the growth plate cartilage fuses in adulthood.
This report contains market size and forecasts of Acromegaly and Gigantism Drugs in global, including the following market information:
Global Acromegaly and Gigantism Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Acromegaly and Gigantism Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Acromegaly and Gigantism Drugs companies in 2021 (%)
The global Acromegaly and Gigantism Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Somatostatin Analogs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Acromegaly and Gigantism Drugs include Ipsen, Novartis and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Acromegaly and Gigantism Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acromegaly and Gigantism Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Acromegaly and Gigantism Drugs Market Segment Percentages, by Type, 2021 (%)
Somatostatin Analogs
GH Receptor Antagonists
Dopamine Agonists
Recombinant Human IGF-1
Global Acromegaly and Gigantism Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Acromegaly and Gigantism Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Acromegaly and Gigantism Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Acromegaly and Gigantism Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Acromegaly and Gigantism Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Acromegaly and Gigantism Drugs revenues share in global market, 2021 (%)
Key companies Acromegaly and Gigantism Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Acromegaly and Gigantism Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ipsen
Novartis
Pfizer
